ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120202. A total of 17 filers reported holding ATYR PHARMA INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $57 | -99.9% | 26,419 | +32.3% | 0.00% | – |
Q2 2022 | $57,000 | -72.6% | 19,963 | -53.3% | 0.00% | -100.0% |
Q2 2021 | $208,000 | -54.5% | 42,724 | -58.4% | 0.00% | -50.0% |
Q1 2021 | $457,000 | +41.9% | 102,697 | +23.7% | 0.00% | +100.0% |
Q4 2020 | $322,000 | +19.7% | 83,052 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $269,000 | -10.9% | 83,052 | +22.2% | 0.00% | 0.0% |
Q2 2020 | $302,000 | +182.2% | 67,964 | +122.3% | 0.00% | – |
Q3 2019 | $107,000 | – | 30,576 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Telemetry Investments, L.L.C. | 624,000 | $1,367 | 2.16% |
Tikvah Management LLC | 1,350,833 | $2,958,324 | 1.41% |
VR Adviser, LLC | 1,171,436 | $2,565,445 | 0.43% |
TANG CAPITAL MANAGEMENT LLC | 123,430 | $270,312 | 0.04% |
FEDERATED HERMES, INC. | 5,231,600 | $11,457,204 | 0.03% |
Alyeska Investment Group, L.P. | 1,378,747 | $3,019,456 | 0.03% |
Walleye Capital LLC | 750,000 | $1,642,500 | 0.03% |
Tower Research Capital LLC (TRC) | 17,443 | $38 | 0.00% |
CITIGROUP INC | 428,460 | $938,327 | 0.00% |
PFS Partners, LLC | 406 | $890 | 0.00% |